ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Pro-ATO/Allicin Liposomes for Dual-Pathway Targeting of p53-Mutant Tumors.

Xiaoling Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.